Installation and Qualification Successfully Completed for Closed-System Filler for Pre-Filled Syringes, Vials, and CartridgesOffers ...
WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of Lifecore Biomedical, Inc. (NASDAQ: LFCR) between October 7, 2020 and March 19, 2024, both dates inclusive ...
Premier Biomedical, Inc., a research-based company, discovers and develops medical products for the treatment of PTSD, cancer, and various other diseases. It offers pain management products ...
NDAQ:LFCR) Lifecore Biomedical, Inc. Is Being Sued For Violating Securities Laws And Impacted Shareholders Should Lend A Hand To The Schall Law Firm ...
Lifecore Biomedical, Inc. (NASDAQ:LFCR) Q4 2024 Earnings Call Transcript August 27, 2024 Operator: Greetings, and welcome to the Lifecore Biomedical Q4 and Full Year 2024 Earnings Call.
Clearside Biomedical Inc (CLSD) stock saw a decline, ending the day at $1.23 which represents a decrease of $-0.12 or -8.89% from the prior close of $1.35. The stock opened at $1.38 and touched a low ...
Avivo Biomedical Inc. (‘Avivo’, avivobio.com), a leading innovator in blood type conversion for organ transplantation and ...
NEW YORK, Sept. 17, 2024 (GLOBE NEWSWIRE) -- Impact BioMedical Inc. (NYSE American: IBO), a company discovering and developing new offerings in human healthcare and wellness, today announced the ...
NEW YORK, Sept. 16, 2024 (GLOBE NEWSWIRE) -- (NYSE American: DSS), a dedicated supporter and investor in Impact BioMedical ...